Penobscot Investment Management’s Boston Scientific BSX Stock Holding History

Penobscot Investment Management’s Portfolio BSX Stock Details BSX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-17,212	Closed	-$1.08M	–	319
2026 Q1	$1.08M	Sell	17,212 -36,803	-68%	-$2.94M	0.08%	164
2025 Q4	$5.15M	Buy	54,015 +2,355	+5%	+$231K	0.39%	61
2025 Q3	$5.04M	Buy	51,660 +9,053	+21%	+$938K	0.39%	61
2025 Q2	$4.58M	Buy	42,607 +10,177	+31%	+$1.03M	0.39%	61
2025 Q1	$3.27M	Buy	32,430 +4,075	+14%	+$410K	0.31%	71
2024 Q4	$2.53M	Buy	28,355 +11,725	+71%	+$1.03M	0.23%	90
2024 Q3	$1.39M	Buy	16,630 +8,260	+99%	+$651K	0.13%	143
2024 Q2	$645K	Buy	+8,370	New	+$613K	0.06%	184

Other funds holding BSX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

California State Teachers Retirement System (CalSTRS) West Sacramento, California $782B AUM 28.39% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

Penobscot Investment Management's BSX Position: Q2 2026 in Review

Penobscot Investment Management sold out of Boston Scientific (BSX) in Q2 2026, closing a stake of 17,212 shares — an estimated $1.08M sold.

Penobscot Investment Management first reported a position in BSX in Q2 2024 and held it in 8 quarters. The position peaked at $5.15M in Q4 2025. 1,470 funds tracked by Wall St. Rank hold BSX as of Q2 2026.

Penobscot Investment Management reported no remaining Boston Scientific position as of Q2 2026 after selling out during the quarter.
Penobscot Investment Management sold 17,212 Boston Scientific shares in Q2 2026, an estimated $1.08M.
Penobscot Investment Management first reported a position in Boston Scientific in Q2 2024 and held it in 8 quarters.
Penobscot Investment Management's Boston Scientific position peaked at $5.15M in Q4 2025.
1,470 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2026.

Based on Penobscot Investment Management's 13F filing for Q2 2026, filed 24 Jul 2026.